Novel Lentiviral Models of HIV Neuropathogenesis (R01)

The summary for the Novel Lentiviral Models of HIV Neuropathogenesis (R01) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Novel Lentiviral Models of HIV Neuropathogenesis (R01): -Purpose. The National Institute of Neurological Disorders and Stroke (NINDS), the National Institute on Drug Abuse (NIDA), the National Institute of Mental Health (NIMH), and the National Institute on Alcohol Abuse and Alcoholism (NIAAA) invite research grant applications aimed at developing and or refinement of animal or ex vivo cell culture model systems for study of the neurologic complications of AIDS, with or without a history of drug or alcohol use. Recent advances in the development of the SIV model system highlight the power of animal model systems for study of the mechanisms underlying the pathology associated with lentiviral infection in the nervous system. These models will be key for developing therapeutic approaches for the treatment of patients suffering from NeuroAIDS and for understanding the basic biology of infection with HIV/AIDS. -Mechanism of Support. This funding opportunity will use the NIH Research Project (R01) award mechanism, and runs in parallel with a FOA of identical scientific scope, PAS-08-179, that encourages applications under the NIH Exploratory/Developmental (R21) grant award mechanism. For research projects with limited scope to develop animal or ex vivo models, applicants may submit their application in response to the NIH Small Research Grant Program (R03): http://grants.nih.gov/grants/guide/pa-files/PA-06-180.html -Funds Available and Anticipated Number of Awards. NINDS intends to commit a total of up to $1,500,000 in total costs over three years for payment of applications responsive to this FOA and the companion FOA (see above). NIDA and NIMH intend to contribute an additional $500,000 and $400,000 each year, respectively, to these FOAs. NIAAA is not setting aside any specific funds for these FOAs; funding determination will depend on the overall scientific merit of the applications and the availability of funds.
Federal Grant Title: Novel Lentiviral Models of HIV Neuropathogenesis (R01)
Federal Agency Name: National Institutes of Health
Grant Categories: Education Health
Type of Opportunity: Discretionary
Funding Opportunity Number: PAS-08-178
Type of Funding: Grant
CFDA Numbers: 93.242
CFDA Descriptions: Mental Health Research Grants
Current Application Deadline: May 07, 2011
Original Application Deadline: May 07, 2011
Posted Date: Jun 18, 2008
Creation Date: Dec 05, 2008
Archive Date: Jun 07, 2011
Total Program Funding: $1,500,000
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Applicants Eligible for this Grant
State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
Link to Full Grant Announcement
Information not provided
Grant Announcement Contact
NIH OER WebmasterFBOWebmaster@OD.NIH.GOV
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [FBOWebmaster@OD.NIH.GOV]
Similar Government Grants
Explainable Artificial Intelligence for Decoding and Modulating Neural Circuit Activity Li...
Reducing Stigma to Improve HIV/AIDS Prevention, Treatment and Care in Low- and Middle-Inco...
Computational Methods for Integrating Tissue and Single Cell Genomic Data from the Brain (...
Non-Invasive Neurostimulation in AD/ADRD (R01 Clinical Trial Optional)
Limited Competition: Continuation of the Center for Genomic Studies on Mental Disorders (U...
Development of Biomarkers for Mental Health Research and Clinical Utilities: (STTR [R41/R4...
Development of Biomarkers for Mental Health Research and Clinical Utilities (SBIR [R43/R44...
Pharmacologic Agents and Drugs for Mental Disorders (SBIR [R43/R44])
More Grants from the National Institutes of Health
Innovative Approaches to Studying Cancer Communication in the New Information Ecosystem (R...
Innovative Approaches to Studying Cancer Communication in the New Information Ecosystem (R...
Investigations on Primary Immunodeficiency Diseases/Inborn Errors of Immunity (R03 Clinica...
NIDA Program Project Grant Applications (P01 Clinical Trial Optional)
NCI Outstanding Investigator Award (R35 Clinical Trial Not Allowed)

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2019 FederalGrants.com